Vidar Fykse

Treatment of ECL cell carcinoids with octreotide LAR

Vidar Fykse, AK Sandvik, Gunnar Qvigstad et al. · Scandinavian Journal of Gastroenterology · 2004 · 76 citations

Medicine, Oncology, Endocrine Oncology +15

Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids

Constantin S. Jianu, Reidar Fossmark, Unni Syversen et al. · Scandinavian Journal of Gastroenterology · 2010 · 54 citations

Medicine, Endocrinology, Oncology +17

One-year follow-up study of patients with enterochromaffin-like cell carcinoids after treatment with octreotide long-acting release

Vidar Fykse, Arne Kristian Sandvik, Helge L. Waldum · Scandinavian Journal of Gastroenterology · 2005 · 28 citations

Medicine, Endocrinology, Oncology +17

Somatostatin‐receptor 2 (sst₂)‐mediated effects of endogenous somatostatin on exocrine and endocrine secretion of the rat stomach

Vidar Fykse, David H. Coy, Helge L. Waldum et al. · British Journal of Pharmacology · 2005 · 18 citations · Full text

Medicine, Endocrinology, Pharmacology +16

ECL cell histamine mobilization and parietal cell stimulation in the rat stomach studied by microdialysis and electron microscopy

Vidar Fykse, Erik Solligård, M. Bendheim et al. · Acta Physiologica · 2005 · 16 citations

Life Sciences, Endocrinology, Physiology +15